Interleukin 2 in the treatment of acute leukemia

被引:5
作者
Blaise, D [1 ]
Maraninchi, D [1 ]
机构
[1] Inst J Paoli I Calmettes, Cellular Therapy & Hematol Unit, F-13009 Marseille, France
关键词
D O I
10.1016/S0145-2126(98)00115-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:1165 / 1170
页数:6
相关论文
共 29 条
[1]  
BENYUNES MC, 1993, BONE MARROW TRANSPL, V12, P159
[2]   The use of a sequential high dose recombinant interleukin 2 regimen after autologous bone marrow transplantation does not improve the disease free survival of patients with acute leukemia transplanted in first complete remission [J].
Blaise, D ;
Attal, M ;
Pico, JL ;
Reiffers, J ;
Stoppa, AM ;
Bellanger, C ;
Molina, L ;
Nedellec, G ;
Vernant, JP ;
Legros, M ;
Gabus, R ;
Huguet, F ;
Brandely, M ;
Hercend, T ;
Olive, D ;
Maraninchi, D .
LEUKEMIA & LYMPHOMA, 1997, 25 (5-6) :469-478
[3]  
BLAISE D, 1990, BLOOD, V76, P1092
[4]  
Blaise D, 1991, Eur Cytokine Netw, V2, P121
[5]   IMPAIRMENT OF LEUKEMIA-FREE SURVIVAL BY ADDITION OF INTERLEUKIN-2-RECEPTOR ANTIBODY TO STANDARD GRAFT-VERSUS-HOST PROPHYLAXIS [J].
BLAISE, D ;
OLIVE, D ;
MICHALLET, M ;
MARIT, G ;
LEBLOND, V ;
MARANINCHI, D .
LANCET, 1995, 345 (8958) :1144-1146
[6]  
BLAISE D, 1997, 39 ANN M AM SOC HEM
[7]  
CHARAK BS, 1992, BONE MARROW TRANSPL, V9, P479
[8]   TRANSDUCTION OF THE IL2 GENE INTO HUMAN ACUTE-LEUKEMIA CELLS - INDUCTION OF TUMOR REJECTION WITHOUT MODIFYING CELL-PROLIFERATION AND IL2 RECEPTOR EXPRESSION [J].
CIGNETTI, A ;
GUARINI, A ;
CARBONE, A ;
FORNI, M ;
CRONIN, K ;
FORNI, G ;
GANSBACHER, B ;
FOA, R .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (10) :785-791
[9]  
FIERRO MT, 1988, LEUKEMIA, V2, P50
[10]   DOES INTERLEUKIN-2 HAVE A ROLE IN THE MANAGEMENT OF ACUTE-LEUKEMIA [J].
FOA, R .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (09) :1817-1825